Parkinson’s disease

Parkinson’s disease is a progressive neurological disorder characterized by both motor and non-motor problems. The primary underlying cause is dysfunction in the brain, particularly a reduction in the production of the neurotransmitter dopamine.

Stem cells have captured interest as a potential avenue for repairing damaged tissues due to their ability to multiply and generate various cell types. In the realm of neurocognitive disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), stem cell therapy is gaining attention as a potential treatment option.

Current research predominantly focuses on mesenchymal stem cells (MSCs), which possess pluripotent properties and contribute to neurogenesis (formation of new neurons) and angiogenesis (formation of new blood vessels). MSCs also exhibit anti-apoptotic effects, which help prevent the loss of neurons. This is achieved through the release of growth factors, neurotrophins, and cytokines.

While stem cell therapy for Parkinson’s disease is an area of active investigation, further research is needed to fully understand the potential benefits and optimize treatment strategies. However, the pluripotent and neuroregenerative properties of MSCs make them a promising candidate for the development of therapeutic interventions in Parkinson’s disease.

If you or someone you know is affected by Parkinson’s disease, we encourage you to explore the potential of stem cell therapy by scheduling a date with us. Our team can assess your condition and provide information about the latest research and treatment options available.

Alzheimer’s

Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References